相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease
Isabelle Aillaud et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2023)
Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain
Christina M. Moloney et al.
ALZHEIMERS & DEMENTIA (2023)
Lecanemab in Early Alzheimer's Disease
Christopher H. van Dyck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2023)
Scrutinizing the Therapeutic Potential of PROTACs in the Management of Alzheimer's Disease
Shiveena Bhatia et al.
NEUROCHEMICAL RESEARCH (2023)
Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial
Catherine J. Mummery et al.
NATURE MEDICINE (2023)
Cytosolic antibody receptor TRIM21 is required for effective tau immunotherapy in mouse models
Aamir S. Mukadam et al.
SCIENCE (2023)
Single-domain antibody-based noninvasive in vivo imaging of α-synuclein or tau pathology
Yixiang Jiang et al.
SCIENCE ADVANCES (2023)
Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study
Hana Florian et al.
BRAIN (2023)
Donanemab in Early Symptomatic Alzheimer Disease The TRAILBLAZER-ALZ 2 Randomized Clinical Trial
John R. Sims et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)
CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's disease
Kanta Horie et al.
NATURE MEDICINE (2023)
Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet
Cecilia Monteiro et al.
NEUROLOGY (2023)
Donanemab in Early Symptomatic Alzheimer Disease The TRAILBLAZER-ALZ 2 Randomized Clinical Trial
John R. Sims et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)
Tubulin tyrosination regulates synaptic function and is disrupted in Alzheimer's disease
Leticia Peris et al.
BRAIN (2022)
Inhibition of caspase-1 ameliorates tauopathy and rescues cognitive impairment in SAMP8 mice
Meng-Shan Tan et al.
METABOLIC BRAIN DISEASE (2022)
Inhibition of Tau seeding by targeting Tau nucleation core within neurons with a single domain antibody fragment
Clement Danis et al.
MOLECULAR THERAPY (2022)
Pathogenic cis p-tau levels in CSF reflects severity of traumatic brain injury
Alireza Mohsenian Sisakht et al.
NEUROLOGICAL RESEARCH (2022)
Membrane channel hypothesis of lysosomal permeabilization by beta-amyloid
Dmitry V. Zaretsky et al.
NEUROSCIENCE LETTERS (2022)
Targeting tau only extracellularly is likely to be less efficacious than targeting it both intra- and extracellularly
Erin E. Congdon et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2022)
Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment
Jiewen Wang et al.
FRONTIERS IN IMMUNOLOGY (2022)
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease 2019
Emma Nichols et al.
LANCET PUBLIC HEALTH (2022)
Glial cells in Alzheimer?s disease: From neuropathological changes to therapeutic implications
Lee Wei Lim et al.
AGEING RESEARCH REVIEWS (2022)
Highly Specific and Sensitive Target Binding by the Humanized pS396-Tau Antibody hC10.2 Across a Wide Spectrum of Alzheimer's Disease and Primary Tauopathy Postmortem Brains
Lone Helboe et al.
JOURNAL OF ALZHEIMERS DISEASE (2022)
Tauopathies: new perspectives and challenges
Yi Zhang et al.
MOLECULAR NEURODEGENERATION (2022)
Faulty autolysosome acidification in Alzheimer's disease mouse models induces autophagic build-up of Aβ in neurons, yielding senile plaques
Ju-Hyun Lee et al.
NATURE NEUROSCIENCE (2022)
AAV Vector-Mediated Antibody Delivery (A-MAD) in the Central Nervous System
Marika Marino et al.
FRONTIERS IN NEUROLOGY (2022)
Tau immunotherapy in Alzheimer?s disease and progressive supranuclear palsy
Nastaran Karimi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2022)
Common and Specific Marks of Different Tau Strains Following Intra-Hippocampal Injection of AD, PiD, and GGT Inoculum in hTau Transgenic Mice
Isidro Ferrer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
CSF tau microtubule-binding region identifies pathological changes in primary tauopathies
Kanta Horie et al.
NATURE MEDICINE (2022)
A call for better understanding of target engagement in Tau antibody development
Anton Bespalov et al.
DRUG DISCOVERY TODAY (2022)
The hippocampal sparing subtype of Alzheimer's disease assessed in neuropathology and in vivo tau positron emission tomography: a systematic review
Daniel Ferreira et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)
Molecular signatures underlying neurofibrillary tangle susceptibility in Alzheimer's disease
Marcos Otero-Garcia et al.
NEURON (2022)
α-Synuclein fibril-specific nanobody reduces prion-like α-synuclein spreading in mice
Yemima R. Butler et al.
NATURE COMMUNICATIONS (2022)
The contribution of altered neuronal autophagy to neurodegeneration
Alessia Filippone et al.
PHARMACOLOGY & THERAPEUTICS (2022)
Single domain antibodies targeting pathological tau protein: Influence of four IgG subclasses on efficacy and toxicity
Erin E. Congdon et al.
EBIOMEDICINE (2022)
Crosstalk between acetylation and the tyrosination/detyrosination cycle of α-tubulin in Alzheimer's disease
Jose Martinez-Hernandez et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Site-Specific Phospho-Tau Aggregation-Based Biomarker Discovery for AD Diagnosis and Differentiation
Ling Wu et al.
ACS CHEMICAL NEUROSCIENCE (2022)
Neuroinflammation co‐localizes highly with tau in amnestic mild cognitive impairment
Johanna Appleton et al.
Alzheimers & Dementia (2022)
2022 Alzheimer's disease facts and figures
Joseph Gaugler et al.
ALZHEIMERS & DEMENTIA (2022)
Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review
Danko Jeremic et al.
AGEING RESEARCH REVIEWS (2021)
Brain target occupancy of LY3372689, an inhibitor of the O‐GlcNAcase (OGA) enzyme, following administration of single and multiple doses to healthy volunteers
William Kielbasa et al.
Alzheimers & Dementia (2021)
Exosomes induce endolysosomal permeabilization as a gateway by which exosomal tau seeds escape into the cytosol
Juan Carlos Polanco et al.
ACTA NEUROPATHOLOGICA (2021)
CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease
Kanta Horie et al.
BRAIN (2021)
A Single-Chain Variable Fragment Antibody Inhibits Aggregation of Phosphorylated Tau and Ameliorates Tau Toxicity in vitro and in vivo
Sen Li et al.
JOURNAL OF ALZHEIMERS DISEASE (2021)
Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1
Adam D. Cotton et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Fangda Leng et al.
NATURE REVIEWS NEUROLOGY (2021)
Increased neuronal activity in motor cortex reveals prominent calcium dyshomeostasis in tauopathy mice
Qian Wu et al.
NEUROBIOLOGY OF DISEASE (2021)
Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation
Carolina Alquezar et al.
FRONTIERS IN NEUROLOGY (2021)
Tau Oligomers Neurotoxicity
Grazyna Niewiadomska et al.
LIFE-BASEL (2021)
A Tauopathy-Homing and Autophagy-Activating Nanoassembly for Specific Clearance of Pathogenic Tau in Alzheimer's Disease
Heng Sun et al.
ACS NANO (2021)
Neuropathology of progressive supranuclear palsy after treatment with tilavonemab
Shunsuke Koga et al.
LANCET NEUROLOGY (2021)
Distinct phosphorylation profiles of tau in brains of patients with different tauopathies
Nastaran Samimi et al.
NEUROBIOLOGY OF AGING (2021)
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial
Guenter U. Hoeglinger et al.
LANCET NEUROLOGY (2021)
Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trial
Lucy Vivash et al.
BMJ OPEN (2021)
Tau immunotherapy is associated with glial responses in FTLD-tau
Boram Kim et al.
ACTA NEUROPATHOLOGICA (2021)
Reducing acetylated tau is neuroprotective in brain injury
Min-Kyoo Shin et al.
CELL (2021)
Chaperone-mediated autophagy prevents collapse of the neuronal metastable proteome
Mathieu Bourdenx et al.
CELL (2021)
TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy
Carolina Alquezar et al.
SCIENCE ADVANCES (2021)
LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
Green Ahn et al.
NATURE CHEMICAL BIOLOGY (2021)
Acetylated tau inhibits chaperone-mediated autophagy and promotes tau pathology propagation in mice
Benjamin Caballero et al.
NATURE COMMUNICATIONS (2021)
Current Status of Clinical Trials on Tau Immunotherapies
Changyi Ji et al.
DRUGS (2021)
Don't Phos Over Tau: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer's disease and other tauopathies
Yuxing Xia et al.
MOLECULAR NEURODEGENERATION (2021)
Cellular and pathological heterogeneity of primary tauopathies
Dah-eun Chloe Chung et al.
MOLECULAR NEURODEGENERATION (2021)
Tau-targeting antibody therapies: too late, wrong epitope or wrong target?
Edwin Jabbari et al.
NATURE MEDICINE (2021)
Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial
Tien Dam et al.
NATURE MEDICINE (2021)
Cis P-tau underlies vascular contribution to cognitive impairment and dementia and can be effectively targeted by immunotherapy in mice
Chenxi Qiu et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Association of Tau Pathology With Clinical Symptoms in the Subfields of Hippocampal Formation
Xinting Ge et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
Phosphorylation and O-GlcNAcylation of the PHF-1 Epitope of Tau Protein Induce Local Conformational Changes of the C-Terminus and Modulate Tau Self-Assembly Into Fibrillar Aggregates
Francois-Xavier Cantrelle et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)
Administration of AAV-Alpha Synuclein NAC Antibody Improves Locomotor Behavior in Rats Overexpressing Alpha Synuclein
Yun-Hsiang Chen et al.
GENES (2021)
A novel dephosphorylation targeting chimera selectively promoting tau removal in tauopathies
Jie Zheng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's disease
Petr Novak et al.
NATURE AGING (2021)
CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease
Kanta Horie et al.
BRAIN (2021)
A novel small-molecule PROTAC selectively promotes tau clearance to improve cognitive functions in Alzheimer-like models
Weijin Wang et al.
THERANOSTICS (2021)
MAPT/Tau accumulation represses autophagy flux by disrupting IST1-regulated ESCRT-III complex formation: a vicious cycle in Alzheimer neurodegeneration
Qiong Feng et al.
AUTOPHAGY (2020)
From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy
Morvane Colin et al.
ACTA NEUROPATHOLOGICA (2020)
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease A Randomized Clinical Trial
Robert Howard et al.
JAMA NEUROLOGY (2020)
Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome A Randomized Clinical Trial
Richard M. Tsai et al.
JAMA NEUROLOGY (2020)
Targeting selective autophagy by AUTAC degraders
Daiki Takahashi et al.
AUTOPHAGY (2020)
Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains
Tamta Arakhamia et al.
CELL (2020)
Evidence that Brain-Reactive Autoantibodies Contribute to Chronic Neuronal Internalization of Exogenous Amyloid-β1-42 and Key Cell Surface Proteins During Alzheimer's Disease Pathogenesis
Eric L. Goldwaser et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Human tau pathology transmits glial tau aggregates in the absence of neuronal tau
Sneha Narasimhan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Primary Tau Pathology, Not Copathology, Correlates With Clinical Symptoms in PSP and CBD
John L. Robinson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2020)
Novel tau filament fold in corticobasal degeneration
Wenjuan Zhang et al.
NATURE (2020)
Advances and considerations in AD tau-targeted immunotherapy
Alice Bittar et al.
NEUROBIOLOGY OF DISEASE (2020)
Biological subtypes of Alzheimer disease A systematic review and meta-analysis
Daniel Ferreira et al.
NEUROLOGY (2020)
Antibody Therapy Targeting RAN Proteins Rescues C9 ALS/FTD Phenotypes in C9orf72 Mouse Model
Lien Nguyen et al.
NEURON (2020)
bioPROTACs as versatile modulators of intracellular therapeutic targets including proliferating cell nuclear antigen (PCNA)
Shuhui Lim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
The aging lysosome: An essential catalyst for late-onset neurodegenerative diseases
Ralph A. Nixon
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2020)
Conformational change and GTPase activity of human tubulin: A comparative study on Alzheimer's disease and healthy brain
Shima Rajaei et al.
JOURNAL OF NEUROCHEMISTRY (2020)
The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer's disease: a longitudinal PET study
Rola Ismail et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Downregulation of a -Synuclein Protein Levels by an Intracellular Single -Chain Antibody
Yuan-Hsiang Chen et al.
JOURNAL OF PARKINSONS DISEASE (2020)
Antibody RING-Mediated Destruction of Endogenous Proteins
Adel F. M. Ibrahim et al.
MOLECULAR CELL (2020)
Humanized tau antibodies promote tau uptake by human microglia without any increase of inflammation
Monika Zilkova et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Neuronally expressed anti-tau scFv prevents tauopathy-induced phenotypes in Drosophila models
Senthilkumar Krishnaswamy et al.
NEUROBIOLOGY OF DISEASE (2020)
Tau immunotherapies: Lessons learned, current status and future considerations
L. A. Sandusky-Beltran et al.
NEUROPHARMACOLOGY (2020)
Crystal structure of a conformational antibody that binds tau oligomers and inhibits pathological seeding by extracts from donors with Alzheimer's disease
Romany Abskharon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Recent advances in tau-directed immunotherapy against Alzheimer's disease: an overview of pre-clinical and clinical development
Pei Ying Ng et al.
METABOLIC BRAIN DISEASE (2020)
Lysosome-targeting chimaeras for degradation of extracellular proteins
Steven M. Banik et al.
NATURE (2020)
Cryo-EM structures of tau filaments
Sjors H. W. Scheres et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2020)
Insoluble Tau From Human FTDP-17 Cases Exhibit Unique Transmission Properties In Vivo
Sarah A. Weitzman et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2020)
The Role of IgG Subclass in Antibody-Mediated Protection against Carbapenem-Resistant Klebsiella pneumoniae
Michael P. Motley et al.
MBIO (2020)
Astrocytes in Tauopathies
Matthew J. Reid et al.
FRONTIERS IN NEUROLOGY (2020)
Monoclonal full-length antibody against TAR DNA binding protein 43 reduces related proteinopathy in neurons
Silvia Pozzi et al.
JCI INSIGHT (2020)
A single ascending dose study in healthy volunteers to assess the safety and PK of LY3372689, an inhibitor of O‐GlcNAcase (OGA) enzyme
William Kielbasa et al.
Alzheimers & Dementia (2020)
Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer's Disease
Hendrik Wesseling et al.
CELL (2020)
Characterization of tau binding by gosuranemab
Richelle Sopko et al.
NEUROBIOLOGY OF DISEASE (2020)
Dynamics of Internalization and Intracellular Interaction of Tau Antibodies and Human Pathological Tau Protein in a Human Neuron-Like Model
Dov B. Shamir et al.
FRONTIERS IN NEUROLOGY (2020)
A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia
Lucy Vivash et al.
BMJ OPEN (2020)
Pharmacological Modulators of Tau Aggregation and Spreading
Antonio Dominguez-Meijide et al.
BRAIN SCIENCES (2020)
Tau Filament Self-Assembly and Structure: Tau as a Therapeutic Target
Sebastian S. Oakley et al.
FRONTIERS IN NEUROLOGY (2020)
Targeting Endogenous K-RAS for Degradation through the Affinity-Directed Protein Missile System
Sascha Roth et al.
CELL CHEMICAL BIOLOGY (2020)
Open-Label Phase 1 Futility Studies of Salsalate and Young Plasma in Progressive Supranuclear Palsy
Lawren VandeVrede et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2020)
Prevention of Fab-arm exchange and antibody reduction via stabilization of the IgG4 hinge region
Michael W. Handlogten et al.
MABS (2020)
Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer's disease
Malcolm Roberts et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Effect of tau-pathology on charged multivesicular body protein 2b (CHMP2B)
Jiwana Sherin Midani-Kurcak et al.
BRAIN RESEARCH (2019)
Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules
Benjamin Falcon et al.
NATURE (2019)
Microglial activation in early Alzheimer trajectory is associated with higher gray matter volume
Grazia Daniela Femminella et al.
NEUROLOGY (2019)
Tau antibody chimerization alters its charge and binding, thereby reducing its cellular uptake and efficacy
Erin E. Congdon et al.
EBIOMEDICINE (2019)
A walk through tau therapeutic strategies
Santosh Jadhav et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody
Marie Albert et al.
BRAIN (2019)
Tau Phosphorylation Rates Measured by Mass Spectrometry Differ in the Intracellular Brain vs. Extracellular Cerebrospinal Fluid Compartments and Are Differentially Affected by Alzheimer's Disease
Nicolas R. Barthelemy et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Involvement of Oligodendrocytes in Tau Seeding and Spreading in Tauopathies
Isidro Ferrer et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models
M. Catarina Silva et al.
ELIFE (2019)
Phospho-Tau Changes in the Human CA1 During Alzheimer's Disease Progression
Mamen Regalado-Reyes et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial
Adam L. Boxer et al.
LANCET NEUROLOGY (2019)
Recruitment, Retainment, and Biomarkers of Response; A Pilot Trial of Lithium in Humans With Mild Cognitive Impairment
Ashleigh Duthie et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Tau oligomers mediate aggregation of RNA-binding proteins Musashi1 and Musashi2 inducing Lamin alteration
Mauro Montalbano et al.
AGING CELL (2019)
Neuronal FcγRI mediates acute and chronic joint pain
Li Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Compromised function of the ESCRT pathway promotes endolysosomal escape of tau seeds and propagation of tau aggregation
John J. Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Targeting tauopathy with engineered tau-degrading intrabodies
Gilbert Gallardo et al.
MOLECULAR NEURODEGENERATION (2019)
Autoantibodies to synapsin I sequestrate synapsin I and alter synaptic function
Anna Rocchi et al.
CELL DEATH & DISEASE (2019)
cis pT231-Tau Drives Neurodegeneration in Bipolar Disorder
Roghayeh Naserkhaki et al.
ACS CHEMICAL NEUROSCIENCE (2019)
A critical appraisal of amyloid-βtargeting therapies for Alzheimer disease
Francesco Panza et al.
NATURE REVIEWS NEUROLOGY (2019)
AUTACs: Cargo-Specific Degraders Using Selective Autophagy
Daiki Takahashi et al.
MOLECULAR CELL (2019)
Regulation of Antigen Export to the Cytosol During Cross-Presentation
Marine Gros et al.
FRONTIERS IN IMMUNOLOGY (2019)
Electrostatic interactions modulate the differential aggregation propensities of IgG1 and IgG4P antibodies and inform charged residue substitutions for improved developability
James T. Heads et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2019)
Antisense oligonucleotides
Daniel R. Scoles et al.
NEUROLOGY-GENETICS (2019)
Protein phosphatase 2A and tau: an orchestrated 'Pas de Deux'
Goce Taleski et al.
FEBS LETTERS (2018)
Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial
Gordon K. Wilcock et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Selective targeting of 3 repeat Tau with brain penetrating single chain antibodies for the treatment of neurodegenerative disorders
Brian Spencer et al.
ACTA NEUROPATHOLOGICA (2018)
Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial
Gary W. Small et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2018)
Distinct dynamic profiles of microglial activation are associated with progression of Alzheimer's disease
Lorraine Hamelin et al.
BRAIN (2018)
Discovery of a Keap1-dependent peptide PROTAC to knockdown Tau by ubiquitination-proteasome degradation pathway
Mengchen Lu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Progress and Potential Pitfalls
Einar M. Sigurdsson
JOURNAL OF ALZHEIMERS DISEASE (2018)
Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers
James P. Quinn et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Fc gamma receptors are expressed in the developing rat brain and activate downstream signaling molecules upon cross-linking with immune complex
Marianna Stamou et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Tau-targeting therapies for Alzheimer disease
Erin E. Congdon et al.
NATURE REVIEWS NEUROLOGY (2018)
Tau Kinetics in Neurons and the Human Central Nervous System
Chihiro Sato et al.
NEURON (2018)
The Association of Tau With Mitochondrial Dysfunction in Alzheimer's Disease
Ying Cheng et al.
FRONTIERS IN NEUROSCIENCE (2018)
Current Concepts of Antigen Cross-Presentation
Maria Embgenbroich et al.
FRONTIERS IN IMMUNOLOGY (2018)
Phosphorylation of different tau sites during progression of Alzheimer's disease
Joerg Neddens et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Epitope determines efficacy of therapeutic anti-Tau antibodies in a functional assay with human Alzheimer Tau
Jean-Philippe Courade et al.
ACTA NEUROPATHOLOGICA (2018)
Structures of filaments from Pick's disease reveal a novel tau protein fold
Benjamin Falcon et al.
NATURE (2018)
Dynamic assessment of tau immunotherapies in the brains of live animals by two-photon imaging
Qian Wu et al.
EBIOMEDICINE (2018)
Anti-tau conformational scFv MC1 antibody efficiently reduces pathological tau species in adult JNPL3 mice
Francesca Vitale et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Aggregated SOD1 causes selective death of cultured human motor neurons
Chen Benkler et al.
SCIENTIFIC REPORTS (2018)
FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer's disease
Petr Novak et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson's disease model
Diptaman Chatterjee et al.
NPJ PARKINSONS DISEASE (2018)
Interplay of pathogenic forms of human tau with different autophagic pathways
Benjamin Caballero et al.
AGING CELL (2018)
Cellular Uptake of α-Synuclein Oligomer-Selective Antibodies is Enhanced by the Extracellular Presence of α-Synuclein and Mediated via Fcγ Receptors
Gabriel Gustafsson et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2017)
Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology
Rachel H. L. H. Rueli et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease
Julian Dronse et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Curcumin Inhibits Tau Aggregation and Disintegrates Preformed Tau Filaments in vitro
Jitendra Subhash Rane et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
AAV-mediated expression of anti-tau scFvs decreases tau accumulation in a mouse model of tauopathy
Christina Ising et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial
Petr Novak et al.
LANCET NEUROLOGY (2017)
Glial contributions to neurodegeneration in tauopathies
Cheryl E. G. Leyns et al.
MOLECULAR NEURODEGENERATION (2017)
Cytosolic Fc receptor TRIM21 inhibits seeded tau aggregation
William A. McEwan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
p62/SQSTM1/Sequestosome-1 is an N-recognin of the N-end rule pathway which modulates autophagosome biogenesis
Hyunjoo Cha-Molstad et al.
NATURE COMMUNICATIONS (2017)
Cis P-tau is induced in clinical and preclinical brain injury and contributes to post-injury sequelae
Onder Albayram et al.
NATURE COMMUNICATIONS (2017)
Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage
Scott S. Shafiei et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
Characterization of TauC3 antibody and demonstration of its potential to block tau propagation
Samantha B. Nicholls et al.
PLOS ONE (2017)
Prophylactic Active Tau Immunization Leads to Sustained Reduction in Both Tau and Amyloid-β Pathologies in 3xTg Mice
Hameetha Rajamohamedsait et al.
SCIENTIFIC REPORTS (2017)
Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins
William P. Flavin et al.
ACTA NEUROPATHOLOGICA (2017)
Tau Antibody Targeting Pathological Species Blocks Neuronal Uptake and Interneuron Propagation of Tau in Vitro
Chloe K. Nobuhara et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Combined effects of scanning ultrasound and a tau-specific single chain antibody in a tau transgenic mouse model
Rebecca M. Nisbet et al.
BRAIN (2017)
Nociceptive neuronal Fc-gamma receptor I is involved in IgG immune complex induced pain in the rat
Haowu Jiang et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease
Lisa Kirouac et al.
ENEURO (2017)
Internalization of tau antibody and pathological tau protein detected with a flow cytometry multiplexing approach
Dov B. Shamir et al.
ALZHEIMERS & DEMENTIA (2016)
FLEXITau: Quantifying Post-translational Modifications of Tau Protein in Vitro and in Human Disease
Waltraud Mair et al.
ANALYTICAL CHEMISTRY (2016)
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease
Rik Ossenkoppele et al.
BRAIN (2016)
Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging
Lorraine Hamelin et al.
BRAIN (2016)
Potential mechanisms and implications for the formation of tau oligomeric strains
Julia E. Gerson et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2016)
Sweeping antibody as a novel therapeutic antibody modality capable of eliminating soluble antigens from circulation
Tomoyuki Igawa et al.
IMMUNOLOGICAL REVIEWS (2016)
Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies
Nicolas R. Barthelemy et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
A Phase IIa Randomized Control Trial of VEL015 ( Sodium Selenate) in Mild-Moderate Alzheimer's Disease
Charles B. Malpas et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Camelid single-domain antibodies: A versatile tool for in vivo imaging of extracellular and intracellular brain targets
Tengfei Li et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity
Nicolas R. Barthelemy et al.
JOURNAL OF PROTEOME RESEARCH (2016)
Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial
Serge Gauthier et al.
LANCET (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
Charge heterogeneity: Basic antibody charge variants with increased binding to Fc receptors
Beate Hintersteiner et al.
MABS (2016)
Affinity of Tau antibodies for solubilized pathological Tau species but not their immunogen or insoluble Tau aggregates predicts in vivo and ex vivo efficacy
Erin E. Congdon et al.
MOLECULAR NEURODEGENERATION (2016)
Detecting tau in serum of transgenic animal models after tau immunotherapy treatment
Cristina d'Abramo et al.
NEUROBIOLOGY OF AGING (2016)
Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo
Sarah K. Kaufman et al.
NEURON (2016)
Antibody-Mediated Targeting of Tau In Vivo Does Not Require Effector Function and Microglial Engagement
Seung-Hye Lee et al.
CELL REPORTS (2016)
Loss of Bin1 Promotes the Propagation of Tau Pathology
Sara Calafate et al.
CELL REPORTS (2016)
Lipid peroxidation causes endosomal antigen release for cross-presentation
Ilse Dingjan et al.
SCIENTIFIC REPORTS (2016)
Specific Knockdown of Endogenous Tau Protein by Peptide-Directed Ubiquitin-Proteasome Degradation
Ting-Ting Chu et al.
CELL CHEMICAL BIOLOGY (2016)
The Translocon Protein Sec61 Mediates Antigen Transport from Endosomes in the Cytosol for Cross-Presentation to CD8+ T Cells
Matthias Zehner et al.
IMMUNITY (2015)
Distinct Therapeutic Mechanisms of Tau Antibodies PROMOTING MICROGLIAL CLEARANCE VERSUS BLOCKING NEURONAL UPTAKE
Kristen E. Funk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Balancing charge in the complementarity-determining regions of humanized mAbs without affecting pI reduces non-specific binding and improves the pharmacokinetics
Amita Datta-Mannan et al.
MABS (2015)
Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy
Asami Kondo et al.
NATURE (2015)
Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits
Sang-Won Min et al.
NATURE MEDICINE (2015)
Human secreted tau increases amyloid-beta production
Jessica Bright et al.
NEUROBIOLOGY OF AGING (2015)
Charge-mediated influence of the antibody variable domain on FcRn-dependent pharmacokinetics
Angela Schoch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Posttranslational modifications of α-tubulin in alzheimer disease
Fan Zhang et al.
TRANSLATIONAL NEURODEGENERATION (2015)
Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau
Katja Hochgraefe et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
Divergent CSF τ alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy
Dana Wagshal et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Passive immunotherapy of tauopathy targeting pSer413-tau: a pilot study in mice
Tomohiro Umeda et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
The Role of Tau Oligomers in the Onset of Alzheimer's Disease Neuropathology
Maria del Carmen Cardenas-Aguayo et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Ceria Nanoparticles Stabilized by Organic Surface Coatings Activate the Lysosome-Autophagy System and Enhance Autophagic Clearance
Wensi Song et al.
ACS NANO (2014)
Primary age-related tauopathy (PART): a common pathology associated with human aging
John F. Crary et al.
ACTA NEUROPATHOLOGICA (2014)
Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer's disease
Ludovic Collin et al.
BRAIN (2014)
Structure and Mechanism of Action of Tau Aggregation Inhibitors
Katryna Cisek et al.
CURRENT ALZHEIMER RESEARCH (2014)
Estimation of polyclonal IgG4 hybrids in normal human serum
Elizabeth Young et al.
IMMUNOLOGY (2014)
Neuronal uptake of anti-Hu antibody, but not anti-Ri antibody, leads to cell death in brain slice cultures
John E. Greenlee et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Antibody-Derived In Vivo Imaging of Tau Pathology
Senthilkumar Krishnaswamy et al.
JOURNAL OF NEUROSCIENCE (2014)
Passive Immunization with Tau Oligomer Monoclonal Antibody Reverses Tauopathy Phenotypes without Affecting Hyperphosphorylated Neurofibrillary Tangles
Diana L. Castillo-Carranza et al.
JOURNAL OF NEUROSCIENCE (2014)
Framework selection can influence pharmacokinetics of a humanized therapeutic antibody through differences in molecule charge
Bing Li et al.
MABS (2014)
Distinct Tau Prion Strains Propagate in Cells and Mice and Define Different Tauopathies
David W. Sanders et al.
NEURON (2014)
First-in-man tau vaccine targeting structural determinants essential for pathological tau-tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer's disease model
Eva Kontsekova et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Protein phosphatase 2A dysfunction in Alzheimer's disease
Jean-Marie Sontag et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2014)
Repeated immunization of mice with phosphorylated-tau peptides causes neuroinflammation
Lea Rozenstein-Tsalkovich et al.
EXPERIMENTAL NEUROLOGY (2013)
Curcumin Suppresses Soluble Tau Dimers and Corrects Molecular Chaperone, Synaptic, and Behavioral Deficits in Aged Human Tau Transgenic Mice
Qiu-Lan Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Antibody Uptake into Neurons Occurs Primarily via Clathrin-dependent Fcγ Receptor Endocytosis and Is a Prerequisite for Acute Tau Protein Clearance
Erin E. Congdon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Two Novel Tau Antibodies Targeting the 396/404 Region Are Primarily Taken Up by Neurons and Reduce Tau Protein Pathology
Jiaping Gu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The constant region affects antigen binding of antibodies to DNA by altering secondary structure
Yumin Xia et al.
MOLECULAR IMMUNOLOGY (2013)
Alzheimer disease therapy-moving from amyloid-β to tau
Ezio Giacobini et al.
NATURE REVIEWS NEUROLOGY (2013)
Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo
Kiran Yanamandra et al.
NEURON (2013)
Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: Focus on davunetide (NAP)
Iddo Magen et al.
NEUROPEPTIDES (2013)
Tau Passive Immunotherapy in Mutant P301L Mice: Antibody Affinity versus Specificity
Cristina d'Abramo et al.
PLOS ONE (2013)
Brain homogenates from human tauopathies induce tau inclusions in mouse brain
Florence Clavaguera et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
IgG Subclass and Heavy Chain Domains Contribute to Binding and Protection by mAbs to the Poly γ-D-glutamic Acid Capsular Antigen of Bacillus anthracis
Maria Hovenden et al.
PLOS PATHOGENS (2013)
The importance of tau phosphorylation for neurodegenerative diseases
Wendy Noble et al.
FRONTIERS IN NEUROLOGY (2013)
Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
Sara Hall et al.
ARCHIVES OF NEUROLOGY (2012)
Interaction of Tau Protein with Model Lipid Membranes Induces Tau Structural Compaction and Membrane Disruption
Emmalee M. Jones et al.
BIOCHEMISTRY (2012)
Proline Isomer-Specific Antibodies Reveal the Early Pathogenic Tau Conformation in Alzheimer's Disease
Kazuhiro Nakamura et al.
CELL (2012)
The constant region contributes to the antigenic specificity and renal pathogenicity of murine anti-DNA antibodies
Yumin Xia et al.
JOURNAL OF AUTOIMMUNITY (2012)
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
Peter T. Nelson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
TPI-287, a New Taxane Family Member, Reduces the Brain Metastatic Colonization of Breast Cancer Cells
Daniel P. Fitzgerald et al.
MOLECULAR CANCER THERAPEUTICS (2012)
The non-fluent/agrammatic variant of primary progressive aphasia
Murray Grossman
LANCET NEUROLOGY (2012)
Hyperphosphorylation and Cleavage at D421 Enhance Tau Secretion
Vanessa Plouffe et al.
PLOS ONE (2012)
Methylene Blue Reduced Abnormal Tau Accumulation in P301L Tau Transgenic Mice
Masato Hosokawa et al.
PLOS ONE (2012)
Isotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody
Daniela Tudor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Reactive Glia not only Associates with Plaques but also Parallels Tangles in Alzheimer's Disease
Alberto Serrano-Pozo et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Neuronal Fc-gamma receptor I mediated excitatory effects of IgG immune complex on rat dorsal root ganglion neurons
Lintao Qu et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models REDUCTION OF TAU PATHOLOGY AND DELAY OF DISEASE PROGRESSION
Xiyun Chai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Sequence-independent Control of Peptide Conformation in Liposomal Vaccines for Targeting Protein Misfolding Diseases
David T. Hickman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain
Allal Boutajangout et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Intraneuronal Amyloid β Oligomers Cause Cell Death Via Endoplasmic Reticulum Stress, Endosomal/Lysosomal Leakage, and Mitochondrial Dysfunction In Vivo
Tomohiro Umeda et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
Granulovacuolar degeneration (GVD) bodies of Alzheimer's disease (AD) resemble late-stage autophagic organelles
K. E. Funk et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2011)
Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
Eliezer Masliah et al.
PLOS ONE (2011)
Biomarkers in frontotemporal lobar degenerations-Progress and challenges
William T. Hu et al.
PROGRESS IN NEUROBIOLOGY (2011)
Mechanistic Studies of Antibody-Mediated Clearance of Tau Aggregates Using an ex vivo Brain Slice Model
Pavan K. Krishnamurthy et al.
Frontiers in Psychiatry (2011)
Lysosomal Proteolysis and Autophagy Require Presenilin 1 and Are Disrupted by Alzheimer-Related PS1 Mutations
Ju-Hyun Lee et al.
CELL (2010)
Evidence for neuronal expression of functional Fc (epsilon and gamma) receptors
Hanneke van der Kleij et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
LiCl Attenuates Thapsigargin-Induced Tau Hyperphosphorylation by Inhibiting GSK-3 beta In Vivo and In Vitro
Zheng-Qi Fu et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model
Niall M. Corcoran et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2010)
Purkinje Cell Death After Uptake of Anti-Yo Antibodies in Cerebellar Slice Cultures
John E. Greenlee et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2010)
Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model
Allal Boutajangout et al.
JOURNAL OF NEUROSCIENCE (2010)
Circular Dichroism reveals evidence of coupling between immunoglobulin constant and variable region secondary structure
Alena Janda et al.
MOLECULAR IMMUNOLOGY (2010)
Fcγ RECEPTORS CONTRIBUTE TO PYRAMIDAL CELL DEATH IN THE MOUSE HIPPOCAMPUS FOLLOWING LOCAL KAINIC ACID INJECTION
S. Suemitsu et al.
NEUROSCIENCE (2010)
Immunopositivity for ESCRT-III subunit CHMP2B in granulovacuolar degeneration of neurons in the Alzheimer's disease hippocampus
Yuu Yamazaki et al.
NEUROSCIENCE LETTERS (2010)
Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models
Janet van Eersel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Improving the solubility of anti-LINGO-1 monoclonal antibody Li33 by isotype switching and targeted mutagenesis
R. Blake Pepinsky et al.
PROTEIN SCIENCE (2010)
Minocycline reduces the development of abnormal tau species in models of Alzheimer's disease
Wendy Noble et al.
FASEB JOURNAL (2009)
Tau Phosphorylation by cdk5 and Fyn in Response to Amyloid Peptide A beta(25-35): Involvement of Lipid Rafts
Paula Hernandez et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Tau - an inhibitor of deacetylase HDAC6 function
Mar Perez et al.
JOURNAL OF NEUROCHEMISTRY (2009)
β-Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin
Qiu-Lan Ma et al.
JOURNAL OF NEUROSCIENCE (2009)
Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo
Aran F. Labrijn et al.
NATURE BIOTECHNOLOGY (2009)
Amyloid activates GSK-3β to aggravate neuronal tauopathy in bigenic mice
Dick Terwel et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Curcumin as Curecumin:: From kitchen to clinic
Ajay Goel et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Isothermal Titration Calorimetry Reveals Differential Binding Thermodynamics of Variable Region-identical Antibodies Differing in Constant Region for a Univalent Ligand
Tarun K. Dam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Cathepsin D expression is decreased in Alzheimer's disease fibroblasts
Lorena Urbanelli et al.
NEUROBIOLOGY OF AGING (2008)
Protective effects of NSAIDs on the development of Alzheimer disease
Steven C. Vlad et al.
NEUROLOGY (2008)
CSF biomarkers in frontotemporal lobar degeneration with known pathology
H. Bian et al.
NEUROLOGY (2008)
Exchanging Murine and Human Immunoglobulin Constant Chains Affects the Kinetics and Thermodynamics of Antigen Binding and Chimeric Antibody Autoreactivity
Marcela Torres et al.
PLOS ONE (2007)
Protein S-guanylation by the biological signal 8-nitroguanosine 3′,5′-cyclic monophosphate
Tomohiro Sawa et al.
NATURE CHEMICAL BIOLOGY (2007)
Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements
Ayodeji A. Asuni et al.
JOURNAL OF NEUROSCIENCE (2007)
CD3 and immunoglobulin G Fc receptor regulate cerebellar functions
Kazuhiro Nakamura et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
The immunoglobulin heavy chain constant region affects kinetic and thermodynamic parameters of antibody variable region interactions with antigen
Marcela Torres et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Increased level of active GSK-3β in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration
K. Leroy et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2007)
beta-amyloid peptide toxicity in organotypic hippocampal slice culture involves Akt/PKB, GSK-3 beta, and PTEN
Melissa Nassif et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Mannose 6-phosphate receptor targeting and its applications in human diseases
M. Gary-Bobo et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2006)
Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein
Hanna Rosenmann et al.
ARCHIVES OF NEUROLOGY (2006)
Ultrastructural characteristics of tau filaments in tauopathies: Immuno-electron microscopic demonstration of tau filaments in tauopathies
Kunimasa Arima
NEUROPATHOLOGY (2006)
Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine
Muhammad Omar Chohan et al.
FEBS LETTERS (2006)
Effects of α-synuclein immunization in a mouse model of Parkinson's disease
E Masliah et al.
NEURON (2005)
Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease
M Grossman et al.
ANNALS OF NEUROLOGY (2005)
Variable-region-ldentical antibodies differing in isotype demonstrate differences in fine specificity and idiotype
M Torres et al.
JOURNAL OF IMMUNOLOGY (2005)
Meta-analysis of nonsteroidal antiinflammatory drug use and risk of dementia
AJM de Craen et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
Expression of Fc epsilon receptor I on primary sensory neurons in mice
T Andoh et al.
NEUROREPORT (2004)
O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's disease
F Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed α-synuclein
C Zhou et al.
MOLECULAR THERAPY (2004)
Direct action of immunoglobulin G on primary sensory neurons through Fc gamma receptor I
T Andoh et al.
FASEB JOURNAL (2004)
Insulin-like growth factor-II/mannose-6-phosphate receptor: Widespread distribution in neurons of the central nervous system including those expressing cholinergic phenotype
C Hawkes et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2003)
Mannose 6-phosphate receptors: New twists in the tale
P Ghosh et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses
EM Mandelkow et al.
NEUROBIOLOGY OF AGING (2003)
p35/Cdk5 pathway mediates soluble amyloid-β peptide-induced tau phosphorylation in vitro
T Town et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Isotype can affect the fine specificity of an antibody for a polysaccharide antigen
GR McLean et al.
JOURNAL OF IMMUNOLOGY (2002)
A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains
HC Tseng et al.
FEBS LETTERS (2002)
Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease
JC Augustinack et al.
ACTA NEUROPATHOLOGICA (2002)
Impaired proteasome function in Alzheimer's disease
JN Keller et al.
JOURNAL OF NEUROCHEMISTRY (2000)
分享论文
